Medigus Ltd ADR Financials
MDGSDelisted Stock | USD 1.73 0.01 0.58% |
Medigus |
Please note, the imprecision that can be found in Medigus' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Medigus Ltd ADR. Check Medigus' Beneish M Score to see the likelihood of Medigus' management manipulating its earnings.
Medigus Stock Summary
Medigus competes with Brainsway, Delcath Systems, Paragon 28, Nexalin Technology, and Bluejay Diagnostics. Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel. Medigus operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 26 people.Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US58471G3002 |
Business Address | 10 Hanechoshet, Tel |
New Symbol | XYLO |
Sector | Health Care Equipment & Supplies |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.medigus.com |
Phone | 972 73 370 4691 |
Currency | USD - US Dollar |
Medigus Key Financial Ratios
Return On Equity | -0.31 | |||
Return On Asset | -0.0663 | |||
Number Of Employees | 77 | |||
Beta | 1.37 |
Medigus Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medigus's current stock value. Our valuation model uses many indicators to compare Medigus value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medigus competition to find correlations between indicators driving Medigus's intrinsic value. More Info.Medigus Ltd ADR is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Medigus by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Medigus Market Pulse
Quote | 1.73 |
Change(%) | 0.58 |
Change | 0.01 |
Open | 1.72 |
Low | 1.7 |
High | 1.85 |
Volume | 0 |
Exchange | NASDAQ |
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Medigus is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Medigus has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Medigus' financials are consistent with your investment objective using the following steps:- Review Medigus' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Medigus' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Medigus' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Medigus' stock is overvalued or undervalued.
Medigus December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Medigus help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Medigus Ltd ADR. We use our internally-developed statistical techniques to arrive at the intrinsic value of Medigus Ltd ADR based on widely used predictive technical indicators. In general, we focus on analyzing Medigus Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Medigus's daily price indicators and compare them against related drivers.
Information Ratio | (0.09) | |||
Maximum Drawdown | 32.6 | |||
Value At Risk | (10.80) | |||
Potential Upside | 8.93 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Medigus Stock
If you are still planning to invest in Medigus Ltd ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medigus' history and understand the potential risks before investing.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |